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Article Information  ABSTRACT 
Received: 21st July 2018  Many prolonged-release dosage forms have employed multiple emulsions (MEs) systems. 
Hence, this study formulated water-in-oil-in-water (w/o/w) MEs of ibuprofen using African 
walnut seed oil (AWSO) for paediatrics use. The MEs were prepared by a two-step 
emulsification method, using Span 80® and Tween 80® as primary and secondary emulsifiers, 
respectively. The MEs were evaluated by their physical properties, drug entrapment efficiency, 
stability and drug release profile. From the study, stable MEs of ibuprofen (100 mg / 5 ml) can be 
prepared with 25 % w/v Span 80® as the primary emulsifier, and 8, 10 or 12 % w/v Tween 80® as 
the secondary emulsifier. The optimum ratios of oil to water in the primary emulsion were 1:1 
and 3:2, while that of primary emulsion to external aqueous phase were 1:1 and 1:2. The amount 
of the ibuprofen released from the MEs was ≤ 35.6 % at 5 hours. The study offers ibuprofen 
emulsions which may require once daily dosing compared to other available paediatric dosage 
forms of the drug which require three to four times dosing daily. It also provides information on 
AWSO as a possible drug carrier in the formulation of w/o/w MEs of ibuprofen for paediatrics. 
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INTRODUCTION 
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) 
used widely in paediatrics for management of pains and fever. 
It is recommended for use in children 3 months and above 
weighing 5 kg upwards at a dose of 5 – 10 mg / kg orally every 
6 – 8 hours with a maximum daily dose of 30 mg / kg [1]. 
Commonly available ibuprofen formulations for paediatric use 
are syrup and suspension (containing 100 mg/ 5 ml dose). 
Ibuprofen powder is insoluble in water but soluble in organic 
solvents [2]. This may justify why it is commonly available in 
capsule, tablet, syrup and suspension dosage forms. It also has 
a bitter taste which may be unacceptable to paediatrics, hence 
the need for effective taste masking. Sweeteners, which are 
used for taste masking, may cause dental caries and diabetes in 
children. A more effective way of masking the taste of drugs 
and also reducing the dosing frequency is very much desirable 
for paediatric drug formulations. A way to achieve this is by 
multiple emulsion formulations. 
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Multiple emulsions (MEs) are dispersed systems in which the 
dispersed phase contains smaller internal droplets of similar 
nature with the continuous phase [3]. Among other types of 
MEs, the water-in-oil-in-water (w/o/w) and oil-in-water-in-oil 
(o/w/o) types are the commonest. The w/o/w MEs comprise of 
internal oil globules containing water droplets and are 
surrounded by an external aqueous phase. The o/w/o MEs, 
however, comprise of internal water globules containing oil 
droplets and are surrounded by an external oil phase. MEs’ 
complex structure allows for different modifications that make 
them suitable for many potential uses than simple emulsions. 
The most commonly studied MEs are the w/o/w types which 
are widely used for pharmaceutical purposes [4]. MEs have 
been employed for controlled and prolonged release of drugs 
from formulations [5, 6, 7] and as intermediate step in 
microencapsulation process [8]. Drugs that have unpleasant 
taste such as bitterness have also been incorporated in the 
internal phase of a multiple emulsion system to mask the taste 
[9]. The basic rationale for these applications is that the drug 
has to transverse interfacial barriers and other phases (than 
where it was incorporated) before its liberation from the 
formulation and subsequent bioavailability [10].  
The oil employed is one of the major factors that affect ME 
formulations. Based on ease of emulsification and stability 
concerns, mineral oils have been more employed than 
vegetable oils in formulating MEs [11]. However, vegetable 
oils are more easily biodegradable and have been found to be 
rich in nutrients which are not available in mineral oils. African 
walnut seed oil (AWSO), for example, is a rich source of 
essential dietary fatty acids – oleic, linoleic and alpha-linolenic 
acids [12]. Dietary minerals such as potassium, magnesium, 
and calcium have been found in significant quantities in walnut 
seed [13]. Its polyphenols content is also higher than other 
common nuts [14].  
AWSO is the oil obtained from matured seeds of African 
walnut, Plukenetia conophora Müll.Arg. (formerly called 
Tetracarpidium conophorum) of Euphorbiaceae family. It is 
native to Nigeria and Cameroon [15]. The high nutritional 
value and numerous health benefits of walnut plant make it an 
important research focus. Literature search of the oil as a 
pharmaceutical excipient revealed that it has not been 
effectively used in drug formulation. Most of the researches on 
the plant stopped at its proximate composition analysis and 
bioactivities. AWSO, being highly nutritive and safe for human 
consumption, can be employed in formulation of oral w/o/w 
MEs of water-insoluble drug like ibuprofen. The study 
therefore aimed to formulate stable prolonged release ibuprofen 
formulations using AWSO.  
 
MATERIALS & METHODS 
Ibuprofen powder (donated by Fidson Healthcare Plc., Sango-
Otta, Nigeria); polyoxyethylene sorbitan monooleate (Tween 
80
®
), sorbitan monooleate (Span 80
®
), methyl-p-amino benzoic 
acid, propyl-p-amino benzoic acid (BDH Chemical Limited, 
Poole, England); phosphate buffer solution (pH 7.4); African 
walnut seed oil and distilled water.  
  
Extraction of AWSO 
Matured African walnut seeds purchased at Atakumosa market, 
Ilesa, Osun State were dried and pulverised with a blender 
(USHA, India). The seed oil was extracted by soxhlet 
extraction using n-hexane as the solvent (solvent residue was 
removed from the oil using a rotary evaporator (Buchi 
Rotavapor R110, Switzerland) at 50 °C). The physicochemical 
properties of the oil were determined using the British 
Pharmacopoeia methods [2].  
 
Formulation of w/o/w MEs of Ibuprofen 
MEs of AWSO without the drug (i.e. blank) were prepared 
with a simple hand mixer (Saisho, Hong Kong) using a two-
step emulsification method [7, 16]. Span 80
® 
and Tween 80
® 
were used as the primary and secondary emulsifiers, 
respectively. The concentrations of the primary and secondary 
emulsifiers, stirring time, ratios of oil phase to water phase of 
the primary emulsion and primary emulsion to aqueous phase 
of the secondary emulsion, were as indicated in Table 1. The 
primary water-in-oil (w/o) emulsion was prepared by addition 
of water to the oil containing Span 80
® 
with continuous stirring 
at 1700 revolution per minute (rpm). This was then added to 
water containing Tween 80
®
 with continuous stirring at 1400 
rpm to form the final MEs.  
 
After 28 days of storage, the blank MEs that did not show oil 
phase separation were selected for preparing 50 mg/ 5 ml, 100 
mg/ 5 ml 150 mg/ 5 ml w/o/w MEs of ibuprofen (Table 2). 
Becher [17] suggested that oil-soluble and water-soluble 
materials, respectively, be placed in the oil phase and aqueous 
phase before adding the phases together. The drug being 
insoluble in water was incorporated in the oil phase of the 
primary emulsion prior to addition of the internal aqueous 
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phase. The primary emulsion was stirred at 1700 rpm for 5 
minutes while the secondary emulsion was stirred at 1400 rpm 
for 30 seconds. Preservatives, 0.1%w/v methyl-p-amino 
benzoic acid and 0.05%w/v propyl-p-amino benzoic acid, were 
added to the external aqueous phase and the oil phase, 
respectively. Preservatives were added to prevent the growth of 
microorganisms in the w/o/w MEs. Methyl-p-amino- and 
propyl-p-amino- benzoic acid, which are most commonly used 
preservatives, were added to the external aqueous phase and the 
oil phase, respectively.  
 
Evaluation of the MEs of Ibuprofen 
Determination of degree of creaming 
A calibrated test-tube was filled with the multiple emulsion up 
to a labelled mark and the volume ratio of the ‘less cloudy’ 
aqueous phase (Ha) to the total volume of the emulsion (H0) at 
room temperature was recorded at 24 hours, 7 days, 14 days 
and 28 days. The percentage creaming (%) was calculated for 
each formulation as: 
                      
  
  
                   Equation 1 
Each result was an average of three determinations. 
 
Droplet size analysis 
The droplet sizes of the multiple emulsion droplets were 
measured with a light microscope to which digital AmScope 
camera (Omax, China) was attached, 24 hours after 
preparation. The emulsion was diluted to 1 in 100 using 70% 
v/v aqueous propylene glycol [18]. A minimum of six fields of 
view were observed using the camera. The number of multiple 
emulsion droplets and simple emulsion droplets (those that 
appeared as o/w type) formed was determined by counting each 
droplet per category. The fraction of multiple emulsion droplets 
formed was hence calculated.  
 
Table 1: Blank AWSO multiple emulsions 
Code 
 
 
Primary emulsion Secondary emulsion 
Oil : Water 
(v/v) ratio 
Span 80
®
 
(%w/v) 
Stirring time 
(min) 
(W/O) : Water 
(v/v) ratio 
Tween 80
®
 (%w/v) 
Stirring time 
(min) 
A1 1:1 25 10 1:1 12 2 
A2 1:1 25 10 3:7 12 2 
A3 1:1 25 10 1:2 12 2 
A4 3:2 25 10 1:1 12 2 
A5 3:2 25 10 3:7 12 2 
A6 3:2 25 10 1:2 12 2 
B1 1:1 25 10 1:1 10 2 
B2 1:1 25 10 3:7 10 2 
B3 1:1 25 10 1:2 10 2 
B4 3:2 25 10 1:1 10 2 
B5 3:2 25 10 3:7 10 2 
B6 3:2 25 10 1:2 10 2 
C1 1:1 25 10 1:1 8 2 
C2 1:1 25 10 3:7 8 2 
C3 1:1 25 10 1:2 8 2 
C4 3:2 25 10 1:1 8 2 
C5 3:2 25 10 3:7 8 2 
C6 3:2 25 10 1:2 8 2 
D1 1:1 25 10 1:1 6 2 
D2 1:1 25 10 3:7 6 2 
D3 1:1 25 10 1:2 6 2 
D4 3:2 25 10 1:1 6 2 
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D5 3:2 25 10 3:7 6 2 
D6 3:2 25 10 1:2 6 2 
E1 1:1 15 10 1:1 10 2 
E2 1:1 15 10 3:7 10 2 
E3 1:1 15 10 1:2 10 2 
E4 3:2 15 10 1:1 10 2 
E5 3:2 15 10 3:7 10 2 
E6 3:2 15 10 1:2 10 2 
F1 1:1 20 10 1:1 10 2 
F2 1:1 20 10 3:7 10 2 
F3 1:1 20 10 1:2 10 2 
F4 3:2 20 10 1:1 10 2 
F5 3:2 20 10 3:7 10 2 
F6 3:2 20 10 1:2 10 2 
G1 1:1 30 10 1:1 10 2 
G2 1:1 30 10 3:7 10 2 
G3 1:1 30 10 1:2 10 2 
G4 3:2 30 10 1:1 10 2 
G5 3:2 30 10 3:7 10 2 
G6 3:2 30 10 1:2 10 2 
 
Table 2: Composition of multiple emulsion formulations of ibuprofen 
Code 
Emulsifiers’ 
concentration (% w/v) 
Oil : Water (v/v) ratio 
(primary emulsion) 
(W/O): Water (v/v) 
ratio 
Ibuprofen concentration (mg/ 5 ml) 
A1a S25T12 
S25T12 
S25T12 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
50 
A1b 100 
A1c 150 
A2a S25T12 
S25T12 
S25T12 
1 : 1 
1 : 1 
1 : 1 
3 : 7 
3 : 7 
3 : 7 
50 
A2b 100 
A2c 150 
A3a S25T12 
S25T12 
S25T12 
1 : 1 
1 : 1 
1 : 1 
1 : 2 
1 : 2 
1 : 2 
50 
A3b 100 
A3c 150 
A6a S25T12 
S25T12 
S25T12 
3 : 2 
3 : 2 
3 : 2 
1 : 2 
1 : 2 
1 : 2 
50 
A6b 100 
A6c 150 
B1a S25T10 
S25T10 
S25T10 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
50 
B1b 100 
B1c 150 
B4a S25T10 
S25T10 
S25T10 
3 : 2 
3 : 2 
3 : 2 
1 : 1 
1 : 1 
1 : 1 
50 
B4b 100 
B4c 150 
C1a S25T8 
S25T8 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
50 
C1b 100 
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C1c S25T8 1 : 1 1 : 1 150 
C4a S25T8 
S25T8 
S25T8 
3 : 2 
3 : 2 
3 : 2 
1 : 1 
1 : 1 
1 : 1 
50 
C4b 100 
C4c 150 
G1a S30T10 
S30T10 
S30T10 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
1 : 1 
50 
G1b 100 
G1c 150 
S and T are Span 80
®
 and Tween 80
®
, respectively; (W/O) is the fraction of the primary water-in-oil emulsion.  
 
Also, the geometric mean droplet diameter (M) and the 
geometric standard deviation (δg) were calculated using the 
formulae derived by Smith and Jordan [18] for polydispersed 
system: 
       
         
    
   Equation 2 
          
                
 
 
    
  Equation 3 
Where ni is the number of droplets whose diameter lies in an 
interval of which the midpoint is xi.  
 
Stability to centrifugation 
This was done by centrifuging 2.5 ml of each freshly prepared 
formulation in a centrifuge apparatus (Gallenhamp, England) at 
4000 rpm for 15 minutes. The formulations in which there was 
cracking were noted. 
 
Determination of entrapment efficiency (EE) 
A 2.5 ml sample of each formulation was centrifuged at 4000 
rpm for 15 minutes and allowed to stand overnight. The sample 
used for the EE determination was prepared by withdrawing 
0.5 ml of the centrifuged MEs from the base and diluting with 
50 ml of phosphate buffer solution (pH 7.4) before filtering 
with a filter paper (Whatman
®
 1,0.22 mm pore size) [7]. A 1 in 
10 dilution of the filtrate was done before the absorbance was 
measured at 222 nm using a UV spectrophotometer (UV-1800, 
Shimadzu). The entrapment efficiency was calculated using the 
equation below [4, 19] and each value was an average of three 
measurements. 
       
                        –        
                       
             Equation 4 
The free drug was the amount of the drug found in the filtrate. 
 
Accelerated stability study 
The effect of storage temperature on physical properties and 
stability of the most stable 100 mg/ 5 ml ibuprofen w/o/w MEs 
was assessed. Duplicate samples of each selected formulation 
were dispensed into graduated test-tubes and each was stored at 
10°C and 40°C for 4 weeks. At different time intervals, the 
formulations were monitored for degree of creaming, changes 
in viscosity; pH; colour and droplet size. Entrapment efficiency 
of each formulation after the 4 weeks storage period was also 
determined. 
 
Viscosity measurement of the MEs  
It had been established that the viscosity of a non-Newtonian 
system such as emulsion can only be determined by rotational 
viscometers at different shear rates [20]. Thus, NDJ-5S digital 
rotary viscometer (China) operating at different speeds – 6 rpm, 
12 rpm, 30 rpm and 60 rpm was used. The rotor of the 
viscometer (inserted in the formulation at a fixed position) was 
subjected to a torque moment (rotation about a specific point) 
proportional to the viscosity of the formulation. The torque 
moment was measured by the sensors and processed into the 
viscosity (mPa.s) as displayed on the screen. At 28 ± 1 °C, each 
measurement at the varying speeds (increasing order) was done 
at 20 minutes interval. After allowing the sample to rest for 5 
minutes, the viscosity was again determined at the different 
speeds in decreasing order also at 20 minutes interval.  
 
In vitro drug release study  
The drug release from the MEs was done in vitro by dialysis 
method using Spectra/ Por
®
 membrane tubing (Fisher 
Scientific, UK) [21, 22]. Veego (India) digital dissolution test 
apparatus was employed. The dissolution test conditions were 
as specified in Table 3. Samples withdrawn from the 
dissolution medium were balanced by replacement with an 
equal volume of buffer solution maintained at equal 
temperature. The drug content in each withdrawn sample was 
determined spectrophotometrically at 222 nm. The percentage 
of ibuprofen released from the MEs at pre-determined times 
was calculated and each value was an average of three 
determinations.  
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Drug release kinetics  
The dissolution data obtained from the in vitro drug release 
study were computed using Microsoft Excel spreadsheet and 
DDSolver software [23, 24]. Zero-order, first-order, Higuchi, 
Higuchi with lag time, and Korsmeyer-Peppas release kinetics 
models were utilised for the release kinetics of ibuprofen from 
the w/o/w emulsions and are expressed mathematically as 
follows: 
a. Zero-order kinetic model [25, 26]  
              Equation 5 
   is the amount of drug released in time, t;    is the initial 
amount of drug; and    is the zero-order release constant. 
 
Table 3: Dissolution test conditions 
Parameter Material/test condition 
Dissolution medium Phosphate buffer solution (pH 
7.4) 
Dissolution medium volume 700 ml 
Temperature 37.5 
0
C 
Method Basket 
Speed 50 rpm 
Volume withdrawn 5 ml 
Sampling times (min) 15, 30, 60, 90, 120, 180, 240 
and 300 
b. First-order kinetic model [27, 28]  
                Equation 6 
    is the amount of drug released in time, t;    is the initial 
amount of drug; and   is the first-order release constant. The 
drug release is proportional to the remaining amount of drug in 
the formulation [27].  
c. Higuchi model [27, 29]  
           Equation 7 
   is the amount of drug released in time, t; and    is the 
Higuchi release constant. 
d. Higuchi model with lag time [27]  
                 Equation 8 
   is the amount of drug released in time, t;      is the lag time; 
and    is the Higuchi release constant. 
e. Korsmeyer-Peppas model [28, 30]  
  
  
     
     Equation 9 
  
  
 is the drug fraction released in time, t;     is the 
Korsmeyer-Peppas release constant; and n is the drug release 
exponent. 
The Adjusted Coefficient of Determination (R
2
adjusted), Model 
Selection Criterion (MSC) and Akaike Information Criterion 
(AIC), which are goodness of fit parameters, were used to 
select the best drug release model from the MEs [23]. The 
release model with the highest R
2
adjusted (≥ 0.99), MSC (≥ 3.00) 
values and lowest AIC value was chosen as the best-fit model 
[28]. The goodness of fit of the models for each formulation 
was also validated using the DDSolver software to predict the 
percentage of ibuprofen released at 120 min.  
 
Statistical analysis 
The release parameters obtained were subjected to single factor 
Analysis of Variance (ANOVA) at 0.05 alpha value with p < 
0.05 considered statistically significant. 
 
RESULTS AND DISCUSSION 
Physicochemical properties of AWSO used for the study 
The physicochemical properties of the AWSO were as 
presented in Table 4. The golden yellow colour of the AWSO 
is similar to what was obtained in literature [31]. It did not have 
optical activity, indicating the absence of chiral compounds in 
the oil. The weight per millilitre (0.8668 ± 0.0043 g/ml) and 
relative density (0.8640 ± 0.0056) of the oil indicate that it is 
less dense than water. This is of importance in the creaming 
behaviour of an emulsion prepared with the oil. An o/w 
emulsion will show upward creaming if the density of the oil is 
less than that of water and vice-versa [32]. The oil had good 
saponification value which falls within the range given in 
literature (189 – 198 mg KOH/g) [33]. The acid value obtained 
for the oil was 75.954 ± 0.001 mg KOH/g, indicating 
susceptibility of the oil to oxidation being a fixed oil. The oil 
should be kept in air-tight coloured glass containers below 30 
°C. Also, the ester value obtained for the oil used in this study 
showed that it is suitable for oral preparations. Nkafamiya et al. 
[34] reported that oils having higher ester value are more 
suitable for consumption. 
 
Water-in-oil-in-water MEs of ibuprofen using AWSO 
The study attempted to formulate stable MEs of ibuprofen with 
AWSO. The stability of the MEs was evaluated by 
centrifugation, creaming percentage, entrapment efficiency, 
microscopic droplet size analysis, and storage at different 
temperatures. All the formulations had entrapment efficiencies 
(EE) greater than 60% and the EE increased with increase in 
drug concentration (Table 5). During preparation of the MEs, 
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the drug was found to be partially soluble in AWSO. A 
possible strong bond between the oil and the drug could be 
responsible for the observed drug entrapment efficiencies of the 
MEs. However, the formulated MEs, except A1a, A1b, B1a, 
B4a, B4b, B4c, G1a, G1b and G1c, cracked after being 
subjected to centrifugation at 4000 rpm for 15 minutes. 
Centrifugation has been used for determining ‘good’ and ‘bad’ 
emulsions in a series of trial formulations by inducing 
creaming, coalescence and/or oil phase separation.  
 
Table 4: Physicochemical properties of AWSO 
Physicochemical Properties Value 
Colour  Golden yellow 
Relative density at 27 ± 1°C 0.8640 ± 0.0056 
Weight per millilitre at 27±1.5 °C 0.8668 ± 0.0043 g/ml 
Optical rotation at 27 ± 1.5 °C Nil 
Saponification value  193.7 ± 5.0 mg KOH/g  
(189–198 mg   KOH/g) 
Acid value  75.954 ± 0.001 mg KOH/g 
Ester value  117.76 ± 5.012 mg KOH/g 
Kinematic viscosity at 28 ± 1 °C 0.00289 ± 0.00002 mm
2
s
-1
 
pH at 27± 1.5 °C 6.12 
Values in parenthesis are the literature values 
 
‘Bad’ emulsions can be described as those that readily show oil 
phase separation or cracking when subjected to centrifugation 
while ‘good’ emulsions do not show oil phase separation or 
cracking.  The application of centrifugal force in relation to 
creaming of an emulsion is based on Stokes’ equation [35]. 
Centrifugation exaggerates the value of ‘g’ in Stokes’ equation, 
which makes the relationship between the behaviour of an 
emulsion under centrifugation compared against normal storage 
conditions to be unpredictable. Based on this, the MEs that 
cracked may not necessarily be considered unstable.  
The MEs exhibited upward creaming which is characteristic of 
a typical o/w simple emulsion [32]. The oil, being less dense 
than water (Table 4), might have contributed to this behaviour. 
Increasing the ratio of primary emulsion in the final multiple 
emulsion decreased the creaming percentage of the 
formulations on storage (A1 < A3 <A2). The creaming 
percentage also decreased with increase in the drug 
concentration in the MEs. The viscosity of the final MEs which 
depends on the ratio of the primary emulsion to the external 
aqueous phase will increase when this ratio is higher. Higher 
drug concentration would also increase the viscosity of the 
primary emulsion and ultimately that of the final MEs. Based 
on Stokes’ law, creaming will be expected to be less at 
increased viscosity [36]. And it is possible that the drug has a 
synergistic effect on the emulsifiers’ ability to decrease the 
interfacial tension between the internal aqueous phase and the 
oil phase of the w/o/w emulsion. Reduction in interfacial 
tension has been reported to increase stability of emulsion 
systems generally [37].  
The internal and external droplet diameters of the MEs 
increased on storage for 28 days at room temperature (Table 6). 
This may be due to coalescence which is the thinning and 
disruption of the liquid film between the MEs’ droplets 
resulting to the merging of two or more droplets into larger 
ones [38]. A higher oil fraction (from 0.5 to 0.6); increase in 
the emulsifiers’ concentrations and amount of ibuprofen 
resulted in MEs with larger droplets. The decrease in the 
fraction of multiple emulsion droplets with increase in the 
concentration of primary emulsifier from 25 to 30 % w/v may 
be attributed to the ability of ‘excess’ lipophilic emulsifier to 
increase swelling capacity of the oil phase and favour 
formation of simple o/w emulsions [39]. Two or more swollen 
oil phases in a globule may merge, thus increasing the internal 
droplet diameter, or rupture, thus releasing the internal aqueous 
phase to the external aqueous phase and slip back to simple o/w 
system with smaller droplets. 
 
Accelerated stability study  
There was continuous decrease in both the internal and external 
droplet diameters of most of the formulations at 10 
°
C and 40 
°
C compared with those stored at room temperature (Table 7 cf. 
Table 6). This may be due to leakage of the internal aqueous 
phase to the external aqueous phase [40] causing shrinkage of 
the emulsion droplets. Omotosho [41] reported that an expected 
increase in droplet size of MEs by coalescence might be 
counteracted by a decrease in size due to leakage of internal 
aqueous phase (in the oil) to the external aqueous phase. 
Colour change and oil phase separation took place only in the 
formulations stored at 40 
°
C. The change in colour, which 
appeared on the 14
th
 day, may be due to oil phase separation 
which is encouraged by elevated temperatures [7].  
The percentage entrapment efficiency of the MEs changed only 
slightly after storage at extreme temperatures for 28 days 
(Figure 1). This can be indicative of the ability of AWSO based 
w/o/w emulsions to entrap the drug without leaking it to the 
external aqueous phase, even at adverse temperatures. Since the 
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drug was incorporated in the oil phase and not the internal 
aqueous phase, leakage of the internal to the external aqueous 
phase will not likely have significant effect on the entrapment 
efficiency. The viscosity of the formulations also increased at 
these temperatures. This may be due to reduction in the internal 
and external droplet diameters and it has been reported that 
smaller droplet size distribution offers more resistance to flow 
due to an increase in total interfacial area [42].  
Table 5: Stability to centrifugation, creaming, and entrapment efficiency of ibuprofen MEs 
Code 
 
Centrifugation 
Percentage creaming (%) Entrapment 
Efficiency (%) 24 hours 7 days 14 days 28 days 
A1a - 0 0 0 0 67.6 ± 0.0 
A1b - 0 0 0 0 76.8 ± 0.3 
A1c + 0 0 0 0 82.6 ± 0.0 
A2a + 89.2 ± 1.2 Cracked 83.7 ± 0.0 
A2b + 65.0 ± 2.4 79.2 ± 1.2 80.8 ± 1.1 81.6 ± 0.0 87.7 ± 0.0 
A2c + 16.7 ± 0.0 24.2 ± 1.2 24.2 ± 1.2 24.2 ± 1.2 91.4 ± 0.0 
A3a + 88.3 ± 0.0 91.7 ± 0.0 91.7 ± 0.0 91.7 ± 0.0 83.2 ± 0.2 
A3b + 7.5 ± 1.1 7.5 ± 1.1 7.5 ± 1.1 8.3 ± 0.0 86.2 ± 0.1 
A3c + 6.7 ± 2.3 6.7 ± 2.3 7.5 ± 1.1 7.5 ± 1.1 89.9 ± 0.0 
A6a + 45.0 ± 2.4 45.0 ± 2.4 45.0 ± 2.4 45.0 ± 2.4 80.0 ± 0.1 
A6b + 8.3 ± 0.0 9.2 ± 1.2 10.0 ± 2.4 10.9 ± 1.2 89.0 ± 0.0 
A6c + 0 0 0 0 89.6 ± 0.0 
B1a - 0 0 0 0 84.3 ± 0.1 
B1b + 0 0 0 0 89.7 ± 0.0 
B1c + 0 0 0 0 87.1 ± 0.0 
B4a + 0 0 0 0 77.1 ± 0.0 
B4b - 0 0 0 0 90.5 ± 0.0 
B4c - 0 0 0 0 96.1 ± 0.0 
C1a + 0 0 0 0 76.9 ± 0.0 
C1b + 0 0 0 0 86.9 ± 0.0 
C1c + 0 0 0 0 92.6 ± 0.1 
C4a + 0 0 0 0 77.2 ± 0.1 
C4b + 0 0 0 0 84.7 ± 0.0 
C4c + 69.2 ± 1.2 Cracked 93.5 ± 0.1 
G1a - 0 0 0 0 86.1 ± 0.0 
G1b - 0 0 0 0 91.7 ± 0.1 
G1c - 0 0 0 0 93.7 ± 0.0 
+ = cracking present; - = cracking absent 
In vitro release of ibuprofen from the w/o/w MEs 
The in vitro release of ibuprofen from the w/o/w MEs was 
characterised by a slow release with only A6b and A1b 
releasing 35.6 ± 0.3 % and 34.9 ± 0.6 % of the drug 
respectively at 5 hours. This release pattern may be attributed 
to a slow release of the hydrophobic drug from the oil phase 
through the aqueous phase and diffusion through the 
emulsifiers’ interfacial film [9, 22]. This can be used to prolong 
release of active ingredients from the dosage form [7]. It has 
been reported that the middle oil membrane strength in addition 
to the partition and diffusion coefficient of the drug are 
important factors that affect drug release from MEs [10, 19]. 
However, increasing the concentration of the secondary 
emulsifier increased the amount of the drug released from the 
formulation as can be seen in formulations A1b, B1b and C1b 
(Tables 2 and 8). Similar result was also observed by Tirnaksiz 
and Kalsin [40]. This shows that the concentration of the 
hydrophilic secondary emulsifier is critical in drug release from 
w/o/w MEs. 
 
Journal of Applied Pharmaceutical Research 7 (1); 2019: 1 – 9 Ogundipe et. al  
 
 
  Journal of Applied Pharmaceutical Research (JOAPR)| April – June 2018 | Volume 6 Issue 2 |   16 
Table 6: Geometric droplet size and ratio of multiple droplets to simple droplets of multiple emulsion formulations of ibuprofen 
Code 
Geometric mean droplet diameter, M (µm) Fraction of multiple droplets formed 
24 hours 28 days 
24 hours 28 days Internal 
droplet 
External 
droplet 
Internal 
droplet 
External 
droplet 
A1a 6.36 ± 2.13 40.16 ± 1.98 6.93 ± 2.92 90.99 ± 1.57 0.03 9.36 
A1b 6.51 ± 1.88 10.12 ± 1.81 7.24 ± 3.13 20.65 ± 3.10 0.71 1.67 
A1c 9.59 ± 3.56 30.23 ± 1.86 10.00 ± 3.55 64.12 ± 1.86 0.38 1.39 
A2a 37.15 ± 6.62 137.09 ± 1.09 Cracked 0.04 Cracked 
A2b 2.92 ± 1.42 14.29 ± 2.28 4.34 ± 2.31 109.40 ± 1.56 0.44 11.30 
A2c No visible multiple droplets 7.73 ± 2.46 38.46 ± 1.52 0.00 19.69 
A3a 2.57 ± 1.00 34.91 ± 1.22 5.13 ± 2.32 81.10 ± 1.41 0.02 10.67 
A3b 5.55 ± 2.54 17.66 ± 2.52 6.23 ± 2.55 57.15 ± 1.65 0.16 15.60 
A3c 3.52 ± 1.65 44.77 ± 1.51 6.22 ± 2.43 98.63 ± 1.67 0.04 0.51 
A6a 3.50 ± 1.72 31.12 ± 1.32 9.38 ± 3.34 141.25 ± 1.10 0.07 Ruptured 
A6b 8.75 ± 2.38 23.88 ± 1.57 5.68 ± 3.13 45.50 ± 2.21 1.23 Ruptured 
A6c 12.47 ± 2.66 42.17 ± 1.26 19.63 ± 2.94 89.74 ± 1.97 5.17 Ruptured 
B1a 4.47 ± 1.74 23.17 ± 1.77 18.79 ± 2.29 97.72 ± 1.61 0.11 Ruptured 
B1b 2.57 ± 1.00 40.17 ± 1.49 8.84 ± 3.51 56.49 ± 1.83 0.17 0.84 
B1c 
 
3.72 ± 1.68 60.26 ± 1.69 17.14 ± 3.27 87.10 ± 1.29 0.04 10.38 
B4a 2.57 ± 1.00 77.09 ± 1.53 11.30 ± 4.89 120.23 ± 1.33 0.01 12.00 
B4b No visible multiple droplets 7.11 ± 3.55 84.33 ± 1.70 0.00 4.55 
B4c 2.57 ± 1.00 54.20 ± 1.71 14.89 ± 3.06 61.66 ± 2.38 0.00 2.08 
C1a 3.20 ± 1.58 26.30 ± 2.33 4.35 ± 1.79 47.21 ± 1.79 0.08 0.52 
C1b 3.28 ± 1.73 23.93 ± 2.26 5.82 ± 1.82 48.75 ± 2.26 0.06 0.40 
C1c 3.10 ± 1.58 40.46 ± 2.04 3.52 ± 1.65 58.48 ± 1.49 0.03 0.48 
C4a 3.01 ± 1.49 29.85 ± 2.52 3.74 ± 1.76 33.88 ± 2.47 0.15 0.26 
C4b 4.31 ± 1.73 41.30 ± 2.21 4.44 ± 1.84 41.98 ± 1.92 0.14 2.50 
C4c 3.45 ± 1.69 39.36 ± 1.50 Cracked 0.20 Cracked  
G1a No visible 
multiple 
droplets 
2.57 ± 1.00 50.70 ± 1.53 0.00 0.02  
G1b 2.57 ± 1.00 40.27 ± 1.76 3.55 ± 1.91 51.64 ± 1.34 0.06 0.02 
G1c 2.72 ± 1.27 13.37 ± 2.21 2.77 ± 1.32 37.50 ± 1.97 0.03 0.06 
 
It had been reported that the hydrophilic secondary emulsifier 
in higher concentrations can exceed its critical micelle 
concentration, form micelle that may in turn solubilize the 
lipophilic primary emulsifier and move it into the continuous 
aqueous phase. This will likely result in a decrease in the 
concentration of the primary emulsifier and subsequently lead 
to rupture of the oil layer and loss of the internal contents to the 
external environment [43]. Increasing the oil ratio in the 
primary emulsion also increased the percentage of ibuprofen 
released from the w/o/w emulsions. It was explained earlier 
that increase in oil ratio in the primary emulsion increased 
droplet diameters.  
The increase in percentage release can thus be due to thinning 
and possible rupturing of the interfacial film around the 
globules with increase in droplet diameter. Formulation A6b, 
for example, had ruptured ME droplets when observed 
microscopically after 28 days (Table 6). This must be the 
reason it had the highest cumulative drug release.   
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Table 7: Effects of storage temperature on geometric droplet diameter of ibuprofen w/o/w emulsions 
Code 
M (µm) 10 
°
C M (µm) 40 
°
C 
4 days 28 days 4 days 28 days 
Int. Ext. Int. Ext. Int. Ext. Int. Ext. 
A1b 2.64 ±1.18 14.00 ± 1.66 2.64± 1.18 7.93 ± 2.34 2.65 ± 1.20 17.22 ± 1.67 2.61± 1.15 4.94 ± 2.42 
A3b 2.57 ±1.00 9.55 ± 1.43 2.57± 1.00 2.84 ± 1.48 2.77 ± 1.32 19.59 ± 1.95 2.57± 1.00 9.38 ± 1.45 
A6b 2.57 ±1.00 11.0 ± 1.54 2.57± 1.00 3.71 ± 2.00 2.61 ± 1.13 11.38± 2.31 2.57± 1.00 4.50 ± 2.83 
B1b 2.72 ± 1.27 19.14 ± 1.49 2.60± 1.12 9.04 ± 2.66 2.57 ± 1.00 19.54 ± 1.45 2.57± 1.00 5.45 ± 2.99 
C1b 2.57 ± 1.00 10.35 ± 1.39 2.61± 1.13 5.81 ± 2.68 2.62 ± 1.16 8.41 ± 1.98 2.57± 1.00 8.15 ± 2.70 
M: geometric droplet diameter (µm); Int.: internal droplet; Ext.: external droplet  
 
Figure 1: Comparison of the entrapment efficiencies of MEs A1b, A3b, A6b, B1b, and C1b at room temperature (RT) after 24 
hours and after 28 days storage at 10°C and 40°C 
Table 8: The release parameters of formulated ibuprofen w/o/w emulsions 
Formulation 
code 
T15% (min) % drug released in 
120 min 
% drug released in 
300 min 
A1b 5.1 ± 0.5 15.0 ± 0.3 34.9 ± 0.6 
A3b 2.3 ± 0.1 15.2 ± 0.2 28.8 ± 0.2 
A6b 5.6 ± 0.1 21.3 ± 0.5 35.5 ± 0.3 
B1b 2.1 ± 0.2 12.8 ± 0.0 29.3 ± 0.3 
C1b 1.8 ± 0.3 10.4 ± 0.4 23.9 ± 0.2 
 
Drug release kinetics of formulated ibuprofen MEs 
The release mechanism was best described by Korsmeyer-
Peppas model (Table 9). The release exponent, n, values 
obtained for the formulations ranged from 0.582 to 0.918 
indicating non-Fickian diffusion release mechanism [27] and 
this has been associated with more than one type of release 
process [44]. For example, formulation C1b fitted into 
Korsmeyer-Peppas, zero order and first order models while 
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Entrapment efficiencies (%) of the multiple emulsions at RT (after 24 
hours) and after 28 days at 10°C and 40°C  
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formulation A6b fitted into Korsmeyer-Peppas and Higuchi 
with lag-time models. This can be attributed to the many 
factors influencing drug release from multiple emulsion 
systems [9]. The values of n decreased with increasing the 
concentration of the secondary emulsifier; increasing the oil 
ratio in the primary w/o emulsion; and decreasing the primary 
emulsion ratio in the final multiple emulsions. This could be 
due to effect of these factors on the miscibility of the multiple 
emulsion system with the dissolution medium [28]. 
 
 
Table 9: Derived values of release kinetics model fitting parameters from release data of ibuprofen from w/o/w emulsions 
Model Parameter Formulation codes 
A1b A3b A6b B1b C1b 
Zero-order 
 
K0 (min
-1
) 0.122 0.104 0.136 0.098 0.084 
R
2
adjusted 0.965 0.877 0.784 0.980 0.994 
AIC 29.1 35.7 42.9 22.0 11.1 
MSC 3.1 1.8 1.3 3.7 4.8 
D120 min-pre (%) 14.70 (0.30) 12.54 (2.66) 16.37 (4.93) 11.75 (1.05) 10.03 (0.37) 
First-order K1 (mg/min) 0.001 0.001 0.002 0.001 0.001 
R
2
adjusted 0.980 0.918 0.877 0.987 0.998 
AIC 24.9 32.5 38.4 18.7 2.4 
MSC 3.6 2.2 1.8 4.1 5.9 
D120 min-pre (%) 15.96 (0.96) 13.54 (1.66) 18.26 (3.04) 12.53 (0.27) 10.58 (0.18) 
Higuchi KH (mg/min
1/2
) 1.715 1.489 1.969 1.363 1.155 
R
2
adjusted 0.888 0.938 0.985 0.870 0.853 
AIC 38.5 30.2 21.6 36.9 36.0 
MSC 1.9 2.5 3.9 1.8 1.7 
D120 min-pre (%) 18.79 (3.79) 16.32 (1.12) 21.57 (0.27) 14.93 (2.13) 12.66 (2.26) 
Higuchi with lag 
time 
KH (mg/min
1/2
) 2.081 1.581 2.041 1.661 1.453 
R
2
adjusted 0.876 0.974 0.997 0.913 0.958 
AIC 40.0 24.1 8.4 34.4 26.8 
MSC 1.7 3.3 5.6 2.1 2.8 
D120 min-pre (%) 17.70 (2.70) 16.32 (1.12) 21.54 (0.24) 14.20 (1.40) 12.00 (1.60) 
Tlag (min) 47.6 13.4 8.7 46.9 51.7 
Korsmeyer-Peppas KKP (mg/min
n
) 0.333 0.632 1.292 0.202 0.130 
n 0.815 0.666 0.582 0.866 0.918 
R
2
adjusted 0.985 0.976 0.998 0.989 0.997 
AIC 23.0 23.5 7.0 18.3 6.6 
MSC 3.9 3.4 5.8 4.1 5.3 
D120 min-pre (%) 16.45 (1.45) 15.29 (0.09) 20.92 (0.38) 12.76 (0.02) 10.55 (0.15) 
R
2
adjusted: adjusted coefficient of determination; AIC: Akaike Information Criterion; MSC; Model Selection Criterion;D120 min-pre 
(%): predicted percentage drug release in 120 min; Values in bold case represent best goodness of fit for each formulation; Values 
in parentheses are absolute deviation (AD) from experimental values. 
 
Decrease in the concentration of Tween 80
®
 changed the 
release mechanism from Korsmeyer-Peppas to first order 
model (A1b cf. B1b cf. C1b). This implies that the 
concentration of the hydrophilic secondary emulsifier is critical 
in the drug release properties (especially amount release and 
release pattern) of w/o/w MEs. There was no significance 
difference (p > 0.05) between the predicted percentage of 
ibuprofen released in 120 min (D120 min-pre (%)) and the 
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experimental values, thus indicating the suitability of the 
models in describing the release mechanism of ibuprofen from 
the w/o/w MEs. Also, the dissolution test duration may not be 
necessary to be more than 5 hours as the percentage release can 
be predicted using suitable models. 
 
Plate 1 (a and b): Photomicrographs of A1b and A3b, respectively, after 24 hours at room temperature 
 
Plate 2 (a and b): Photomicrographs of A1b and A3b, respectively, after 28 days at room temperature 
 
CONCLUSION 
AWSO is highly nutritive and readily available, and thus can 
be used in place of mineral oils in oral liquid preparations. 
Literature revealed that it has not been effectively used for 
pharmaceutical purposes. This study employed AWSO as the 
drug carrier in formulation of oral w/o/w multiple emulsions of 
ibuprofen. Stable w/o/w MEs of ibuprofen at 100 mg/ 5 ml 
with AWSO, based on this study, can be prepared with 25 % 
w/v Span 80
®
, and 8, 10 or 12 % w/v Tween 80
®
 as the primary 
and secondary emulsifiers, respectively. The optimum ratios of 
oil to water and primary emulsion to external aqueous phase 
were found to be 1:1 and 3:2, and 1:1 and 1:2, respectively. 
Based on the yield of multiple emulsion droplets, 100 mg/ 5 ml 
w/o/w MEs of ibuprofen (A1b and A3b) prepared with 25 % 
w/v Span 80
®
 and 12 % w/v Tween 80
®
 as the primary and 
secondary emulsifiers (Plates 1 and 2), respectively are 
suggested for further development as prolonged release 
paediatric ibuprofen formulation. 
Stability of the w/o/w MEs was found to be affected by many 
factors including the ratio of the oil to water in the primary 
emulsion, fraction of the o/w primary emulsion in the final 
formulation, concentrations of the lipophilic and hydrophilic 
emulsifiers used in the primary and secondary emulsions, 
respectively, and storage temperature. All the formulations had 
entrapment efficiencies above 60 % with increase in ibuprofen 
concentration leading to increase in entrapment efficiency. 
Storage of the multiple emulsions at extreme temperature 
conditions (10 
°
C and 40 
°
C) caused instability in the 
a. A1b at 40X b. A3b at 40X 
a. A1b at 40X b. A3b at 40X 
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formulations. The optimum storage temperature for the 
formulated ibuprofen w/o/w MEs was room temperature. 
The concentration ratio of the primary and secondary 
emulsifiers is critical in drug release properties of w/o/w 
multiple emulsion systems. The release of ibuprofen from the 
w/o/w MEs was characterised by a slow release with only ≤ 
35.6 % drug release after 5 hours from the formulations. The 
release mechanism of the drug from the formulations was best 
described by Korsmeyer-Peppas release model and the release 
mechanism was found to be non-Fickian diffusion which is 
usually associated with more than one type of release process.  
Based on the slow release pattern of this system, it can be used 
to formulate prolonged release ibuprofen emulsion which may 
require once daily dosing compared to other available 
paediatric dosage forms of the drug which require three to four 
times dosing daily. The inherent instability of the ibuprofen 
MEs is a challenge for further study. The study, however, has 
been able to provide information on AWSO as a possible drug 
carrier in the formulation of w/o/w MEs of ibuprofen for 
paediatrics. 
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